Search results
Results From The WOW.Com Content Network
Rasmussen syndrome or Rasmussen's encephalitis is a rare inflammatory neurological disease, characterized by frequent and severe seizures, loss of motor skills and speech, hemiparesis (weakness on one side of the body), encephalitis (inflammation of the brain), and dementia.
The first case of HE was described by Brain et al. in 1966. [10] The patient was a 48-year-old man with hypothyroidism , multiple episodes of encephalopathy , stroke-like symptoms , and Hashimoto's thyroiditis confirmed by elevated antithyroid antibodies.
Steroid ring system. This is a list of neurosteroids , or natural and synthetic steroids that are active on the mammalian nervous system through receptors other than steroid hormone receptors . It includes inhibitory , excitatory , and neurotrophic neurosteroids as well as pheromones and vomeropherines .
The treatment with steroids was stopped and three years later (while still taking buspirone, albuterol, fluticasone and salmeterol inhalers, loratadine and theophylline) the boy showed gradual improvement, but MRI brain scans revealed that the patient's hippocampal volume was 19.5% smaller than that of his twin.
The diagnosis is usually made by a brain scan , in which areas of swelling can be identified. The treatment for PRES is supportive: removal of the cause or causes and treatment of any of the complications, such as anticonvulsants for seizures. PRES may be complicated by intracranial hemorrhage, but this is relatively rare. The majority of ...
3β-Methoxypregnenolone (MAP-4343), or pregnenolone 3β-methyl ether, is a synthetic neuroactive steroid and pregnenolone derivative that interacts with microtubule-associated protein 2 (MAP2) in a similar manner to pregnenolone and is under development for potential clinical use for indications such as the treatment of brain and spinal cord ...
For the diagnosis, brain scans (such as MRI) should be done to rule out other potential causes. Specialty: Neurology: Symptoms: Headache, vision problems, ringing in the ears with the heartbeat [1] [2] Complications: Vision loss [2] Usual onset: 20–50 years old [2] Risk factors: Hypervitaminosis A, obesity, tetracyclines [1] [2] Diagnostic method
Central pontine myelinolysis is a neurological condition involving severe damage to the myelin sheath of nerve cells in the pons (an area of the brainstem). It is predominately iatrogenic (treatment-induced), and is characterized by acute paralysis, dysphagia (difficulty swallowing), dysarthria (difficulty speaking), and other neurological symptoms.